{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T22:52:31Z","timestamp":1767135151499,"version":"build-2238731810"},"update-to":[{"DOI":"10.1002\/14651858.cd010458","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2015,4,29]],"date-time":"2015-04-29T00:00:00Z","timestamp":1430265600000}}],"reference-count":42,"publisher":"Wiley","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd010458.pub2","type":"journal-article","created":{"date-parts":[[2015,4,29]],"date-time":"2015-04-29T07:06:07Z","timestamp":1430291167000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Tafenoquine for preventing relapse in people with\n                    <i>Plasmodium vivax<\/i>\n                    malaria"],"prefix":"10.1002","author":[{"given":"Senaka","family":"Rajapakse","sequence":"first","affiliation":[{"name":"Faculty of Medicine, University of Colombo; Department of Clinical Medicine; 25, Kynsey Road Colombo Sri Lanka"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chaturaka","family":"Rodrigo","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Colombo; Department of Clinical Medicine; 25, Kynsey Road Colombo Sri Lanka"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sumadhya Deepika","family":"Fernando","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Colombo; Department of Parasitology; 25, Kynsey Road, Colombo Sri Lanka 08"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2015,4,29]]},"reference":[{"issue":"9922","key":"10.1002\/14651858.CD010458.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0140-6736(13)62568-4","article-title":"Tafenoquine plus chloroquine for the treatment and relapse prevention of Plasmodium vivax malaria (DETECTIVE): a multicentre, double-blind, randomised, phase 2b dose-selection study","volume":"383","author":"Llanos-Cuentas","year":"2014","journal-title":"Lancet"},{"issue":"4","key":"10.1002\/14651858.CD010458.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1086\/315034","article-title":"Randomized dose-ranging study of the safety and efficacy of WR 238605 (Tafenoquine) in the prevention of relapse of Plasmodium vivax malaria in Thailand","volume":"180","author":"Walsh","year":"1999","journal-title":"Journal of Infectious Diseases"},{"issue":"8","key":"10.1002\/14651858.CD010458.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1086\/424508","article-title":"Randomized trial of 3-dose regimens of tafenoquine (WR238605) versus low-dose primaquine for preventing Plasmodium vivax malaria relapse","volume":"39","author":"Walsh","year":"2004","journal-title":"Clinical Infectious Diseases"},{"key":"10.1002\/14651858.CD010458.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/1475-2875-13-49","article-title":"A retrospective analysis of the protective efficacy of tafenoquine and mefloquine as prophylactic anti-malarials in non-immune individuals during deployment to a malaria-endemic area","volume":"13","author":"Dow","year":"2014","journal-title":"Malaria Journal"},{"issue":"12","key":"10.1002\/14651858.CD010458.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1086\/379718","article-title":"Plasma concentrations of tafenoquine, a new long-acting antimalarial agent, in Thai soldiers receiving monthly prophylaxis","volume":"37","author":"Edstein","year":"2003","journal-title":"Clinical Infectious Diseases"},{"issue":"11","key":"10.1002\/14651858.CD010458.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.trstmh.2008.04.024","article-title":"The efficacy and tolerability of three different regimens of tafenoquine versus primaquine for post-exposure prophylaxis of Plasmodium vivax malaria in the Southwest Pacific","volume":"102","author":"Elmes","year":"2008","journal-title":"Transactions of Royal Society of Tropical Medicine and Hygiene"},{"issue":"9","key":"10.1002\/14651858.CD010458.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1002\/jcph.302","article-title":"Tafenoquine at therapeutic concentrations does not prolong Fridericia-corrected QT interval in healthy subjects","volume":"54","author":"Green","year":"2014","journal-title":"Journal of Clinical Pharmacology"},{"issue":"5","key":"10.1002\/14651858.CD010458.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1086\/367542","article-title":"A randomized, double-blind, placebo-controlled, dose-ranging trial of tafenoquine for weekly prophylaxis against Plasmodium falciparum","volume":"36","author":"Hale","year":"2003","journal-title":"Clinical Infectious Diseases"},{"issue":"3","key":"10.1002\/14651858.CD010458.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"494","DOI":"10.4269\/ajtmh.2007.76.494","article-title":"Tafenoquine for the treatment of recurrent Plasmodium vivax malaria","volume":"76","author":"Kitchener","year":"2007","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"key":"10.1002\/14651858.CD010458.pub2-BIB0010|cit10","unstructured":"Lacerda M Ugwuegbulam C Green J Kellam L Dose-ranging efficacy results from the tafenoquine 'detective' trial: A randomized, double-blind, multi-centre, parallel-group study for the radical cure of subjects with Plasmodium vivax malaria American Journal of Tropical Medicine and Hygiene Washington DC 2013 14"},{"issue":"9220","key":"10.1002\/14651858.CD010458.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1016\/S0140-6736(00)02352-7","article-title":"Malaria chemoprophylaxis with tafenoquine: a randomised study","volume":"355","author":"Lell","year":"2000","journal-title":"Lancet"},{"issue":"6","key":"10.1002\/14651858.CD010458.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S0035-9203(02)90351-2","article-title":"Comparison of tafenoquine (WR238605) and primaquine in the post-exposure (terminal) prophylaxis of vivax malaria in Australian Defence Force personnel","volume":"96","author":"Nasveld","year":"2002","journal-title":"Transactions of Royal Society of Tropical Medicine and Hygiene"},{"issue":"2","key":"10.1002\/14651858.CD010458.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1128\/AAC.00354-09","article-title":"Randomized, double-blind study of the safety, tolerability, and efficacy of tafenoquine versus mefloquine for malaria prophylaxis in nonimmune subjects","volume":"54","author":"Nasveld","year":"2010","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"12","key":"10.1002\/14651858.CD010458.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1086\/324081","article-title":"A new primaquine analogue, tafenoquine (WR 238605), for prophylaxis against Plasmodium falciparum malaria","volume":"33","author":"Shanks","year":"2001","journal-title":"Clinical Infectious Diseases"},{"issue":"8","key":"10.1002\/14651858.CD010458.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1086\/424468","article-title":"Efficacy of monthly tafenoquine for prophylaxis of Plasmodium vivax and multidrug-resistantP. falciparum malaria","volume":"190","author":"Walsh","year":"2004","journal-title":"Journal of Infectious Diseases"},{"key":"10.1002\/14651858.CD010458.pub2-BIB0016|cit16","unstructured":"A Phase I Study to Investigate the Hemolytic Potential of tafenoquine in Healthy Subjects With Glucose-6-phosphate Dehydrogenase Deficiency and the Safety and Tolerability of tafenoquine in Acute Plasmodium vivax Malaria Patients With Glucose-6-phosphate Dehydrogenase Deficiency Ongoing study July 2009"},{"key":"10.1002\/14651858.CD010458.pub2-BIB0017|cit17","unstructured":"A Randomized, Active-control, Double-blind, Double-dummy Study to Evaluate the Efficacy and Safety of Tafenoquine for the Treatment of Plasmodium vivax in Adults Ongoing study September 2003"},{"key":"10.1002\/14651858.CD010458.pub2-BIB0018|cit18","unstructured":"A Randomized, Double-Blind, Double Dummy, Comparative, Multicenter Study to Assess the Incidence of Hemolysis, Safety, and Efficacy of Tafenoquine (SB-252263, WR238605) Versus Primaquine in the Treatment of Subjects With Plasmodium Vivax Malaria Ongoing study September 2014"},{"issue":"9","key":"10.1002\/14651858.CD010458.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1086\/424663","article-title":"Primaquine therapy for malaria","volume":"39","author":"Baird","year":"2004","journal-title":"Clinical Infectious Diseases"},{"issue":"5","key":"10.1002\/14651858.CD010458.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"1293-4","DOI":"10.1128\/AAC.42.5.1293","article-title":"Prophylaxis of Plasmodium falciparum infection in a human challenge model with WR 238605, a new 8-aminoquinoline antimalarial","volume":"42","author":"Brueckner","year":"1998","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"5","key":"10.1002\/14651858.CD010458.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"645-9","DOI":"10.4269\/ajtmh.1998.58.645","article-title":"First-time-in-humans safety and pharmacokinetics of WR 238605, a new antimalarial","volume":"58","author":"Brueckner","year":"1998","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"issue":"2","key":"10.1002\/14651858.CD010458.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"188","DOI":"10.4269\/ajtmh.2009.80.188","article-title":"Methemoglobinemia and adverse events in Plasmodium vivax malaria patients associated with high doses of primaquine treatment","volume":"80","author":"Carmona-Fonseca","year":"2009","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"issue":"2624","key":"10.1002\/14651858.CD010458.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1126\/science.101.2624.377","article-title":"Plasmodium vivax Chesson strain","volume":"101","author":"Ehrman","year":"1945","journal-title":"Science"},{"issue":"9752","key":"10.1002\/14651858.CD010458.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/S0140-6736(10)61500-0","article-title":"Call\u00a0to\u00a0action:\u00a0priorities\u00a0for\u00a0malaria\u00a0elimination","volume":"376","author":"Feachem","year":"2010","journal-title":"Lancet"},{"issue":"4","key":"10.1002\/14651858.CD010458.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/S1995-7645(11)60098-9","article-title":"Chemoprophylaxis\u00a0in\u00a0malaria:\u00a0drugs,\u00a0evidence\u00a0of\u00a0efficacy\u00a0and\u00a0costs","volume":"4","author":"Fernando","year":"2011","journal-title":"Asian Pacific Journal of Tropical Medicine"},{"key":"10.1002\/14651858.CD010458.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1186\/1475-2875-10-351","article-title":"Primaquine\u00a0in\u00a0vivax\u00a0malaria: an\u00a0update\u00a0and\u00a0review\u00a0on\u00a0management\u00a0issues","volume":"10","author":"Fernando","year":"2011","journal-title":"Malaria Journal"},{"issue":"2","key":"10.1002\/14651858.CD010458.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"203","DOI":"10.4269\/ajtmh.2007.76.203","article-title":"Regional differences in the response of Plasmodium vivax malaria to primaquine as anti-relapse therapy","volume":"76","author":"Goller","year":"2007","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"key":"10.1002\/14651858.CD010458.pub2-BIB0028|cit28","unstructured":"McMaster University GRADEpro 2014"},{"issue":"3","key":"10.1002\/14651858.CD010458.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1093\/oxfordjournals.aje.a117250","article-title":"Quality scores are useless and potentially misleading","volume":"140","author":"Greenland","year":"1994","journal-title":"American Journal of Epidemiology"},{"issue":"7414","key":"10.1002\/14651858.CD010458.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"557-60","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"British Medical Journal"},{"key":"10.1002\/14651858.CD010458.pub2-BIB0031|cit31","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"3","key":"10.1002\/14651858.CD010458.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"402","DOI":"10.4269\/ajtmh.2006.75.402","article-title":"Primaquine: report from CDC expert meeting on malaria chemoprophylaxis I","volume":"75","author":"Hill","year":"2006","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"key":"10.1002\/14651858.CD010458.pub2-BIB0033|cit33","article-title":"Chapter 6: Searching for studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1 [updated March 2011].","volume-title":"Available from www.cochrane-handbook.org","author":"Lefebvre","year":"2011"},{"issue":"4","key":"10.1002\/14651858.CD010458.pub2-BIB0034|cit34","first-page":"187","article-title":"Tafenoquine: a new 8- aminoquinoline","volume":"36","author":"Prashar","year":"2009","journal-title":"Medical Journal of Zambia"},{"issue":"4","key":"10.1002\/14651858.CD010458.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/S1413-8670(10)70084-2","article-title":"Clinical aspects of hemolysis in patients with P. vivax malaria treated with primaquine, in the Brazilian Amazon","volume":"14","author":"Ramos J\u00fanior","year":"2010","journal-title":"Brazilian Journal of Infectious Diseases"},{"issue":"11","key":"10.1002\/14651858.CD010458.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.3201\/eid1211.060613","article-title":"Plasmodium vivax malaria relapses after primaquine prophylaxis","volume":"12","author":"Reddy","year":"2006","journal-title":"Emerging Infectious Diseases"},{"key":"10.1002\/14651858.CD010458.pub2-BIB0037|cit37","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2014"},{"issue":"8673","key":"10.1002\/14651858.CD010458.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/S0140-6736(89)91792-3","article-title":"Plasmodium vivax resistance to chloroquine?","volume":"2","author":"Rieckmann","year":"1989","journal-title":"Lancet"},{"issue":"3","key":"10.1002\/14651858.CD010458.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.pt.2009.12.005","article-title":"Targeting the hypnozoite reservoir of Plasmodium vivax: the hidden obstacle to malaria elimination","volume":"26","author":"Wells","year":"2010","journal-title":"Trends in Parasitology"},{"key":"10.1002\/14651858.CD010458.pub2-BIB0040|cit40","volume-title":"International travel and health","author":"World Health Organization","year":"2009"},{"key":"10.1002\/14651858.CD010458.pub2-BIB0041|cit41","unstructured":"World Health Organization Malaria. Fact sheet N 0 94 http:\/\/www.who.int\/mediacentre\/factsheets\/fs094\/en\/"},{"issue":"3","key":"10.1002\/14651858.CD010458.pub2-BIB0042|cit42","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010458","article-title":"Tafenoquine for Plasmodium vivax malaria infection","author":"Rajapakse","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"}],"updated-by":[{"DOI":"10.1002\/14651858.cd010458.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2020,9,6]],"date-time":"2020-09-06T00:00:00Z","timestamp":1599350400000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD010458.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T18:44:22Z","timestamp":1628534662000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD010458.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Infectious Diseases Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2015,4,29]]},"references-count":42,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd010458.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,29]]}}}